# EDGAR Filing Document

**Accession Number:** 0001164470
**File Stem:** 0001213900-25-070781
**Filing Date:** 2025-8
**Character Count:** 7977
**Document Hash:** 191d5f4f747a37691a92c05b52f44d32
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-070781.hdr.sgml**: 20250801

**ACCESSION NUMBER**: 0001213900-25-070781

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250730

**FILED AS OF DATE**: 20250801

**DATE AS OF CHANGE**: 20250801

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** LILLIE JAMES E
- **CENTRAL INDEX KEY:** 0001164470

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42524
- **FILM NUMBER:** 251177576

**MAIL ADDRESS:**
- **STREET 1:** C/O MOORE CORPORATION LIMITED
- **STREET 2:** ONE CANTERBURY GREEN
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06901
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ACUREN CORP
- **CENTRAL INDEX KEY:** 0002032966
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 14434 MEDICAL COMPLEX DRIVE
- **STREET 2:** #100
- **CITY:** TOMBALL
- **STATE:** TX
- **ZIP:** 77377
- **BUSINESS PHONE:** 800-218-7450

**MAIL ADDRESS:**
- **STREET 1:** 14434 MEDICAL COMPLEX DRIVE
- **STREET 2:** #100
- **CITY:** TOMBALL
- **STATE:** TX
- **ZIP:** 77377

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>LILLIE JAMES E<br><sub>(Last) (First) (Middle)</sub><br>C/O ACUREN CORPORATION<br>14434 MEDICAL COMPLEX DRIVE, SUITE 100<br><sub>(Street)</sub><br>TOMBALL, TX 77377<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-07-30 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>ACUREN CORP [ TIC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-07-30 |  | M |  | 10000 | A | 0<sup>(1)</sup> | 10000 | D |  |
| Common Stock |  |  |  |  |  |  |  | 1746169<sup>(2)</sup> | I | By Mariposa Acquisition IX, LLC<sup>(2)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(3)</sup> | 2025-07-30 |  | M |  |  | 10000 | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 10000 | $0.00 | 0 | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2025-07-31 |  | A |  | 9017 |  | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 9017 | $0.00 | 9017 | D |  |
| Series A Preferred Stock | <sup>(6)</sup> |  |  |  |  |  |  | <sup>(6)</sup> | <sup>(6)</sup> | Common Stock | 92500<sup>(2)</sup> |  | 92500 | I | By Mariposa Acquisition IX, LLC<sup>(2)</sup> |

---

### Footnotes:

(1) On July 30, 2025, 10,000 of the Reporting Person's restricted stock units were settled for an equal number of shares of the Issuer's Common Stock.

(2) Mariposa Acquisition IX, LLC ("Mariposa IX") directly holds (i) 18,877,500 shares of Common Stock and (ii) 1,000,000 shares of Series A Preferred Stock ("Preferred Stock") convertible into shares of Common Stock for no additional consideration as set forth below. Mr. Lillie holds a limited liability company interest in Mariposa IX and, as a result, may be deemed to have a pecuniary interest in approximately (i) 1,746,169 shares of Common Stock and (ii) 92,500 shares of Common Stock issuable upon conversion of the Preferred Stock held by Mariposa IX. Mr. Lillie disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by Mariposa IX except to the extent of his pecuniary interest therein. Mr. Lillie does not have beneficial ownership over the shares of Common Stock and Preferred Stock held directly by Mariposa IX.

(3) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

(4) These restricted stock units vest on July 30, 2025 (the one-year anniversary of the grant date).

(5) These restricted stock units vest on July 31, 2026 (the one-year anniversary of the grant date).

(6) The Series A Preferred Stock is convertible at any time at the election of the holder, on a one-for-one basis, into shares of Common Stock for no additional consideration. The Series A Preferred Stock shall automatically convert into Common Stock upon the earlier of (i) immediately following the "change of control dividend date" (as defined in the Issuer's certificate of incorporation) and (ii) December 31, 2034.

**Signature:** /s/ Fiona Sutherland, Attorney-in-Fact  
**Date:** 2025-08-01

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**